The current study examines the impact of COVID-19 experiences on anxiety and depression in a sample of <i>BRCA1/2</i> -positive women in the U.S. <i>Methods.</i> 211 <i>BRCA1/2</i> -positive women from medically underserved backgrounds completed an online survey. This evidence concerns the gene BRCA1 and depressive symptom measurement.